NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) income statement
NMTCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 11/3080% below fair value
$0.76+0.05 (+7.73%)
Close on Nov 18, 2026Market cap $6.93MP/E –Yield –
NEUROONE MEDICAL TECHNOLOGIES Corp income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 55.6%
- Operating margin
- -83.4%
- Net margin
- -78.6%
- Return on equity, FY2025
- -91.3%
Financial strength
- Current ratio
- 2.84
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 100.3%
Valuation
- P/E ratio
- –
- Price to sales
- 0.73
- Price to book
- 1.84
- Dividend yield
- –
See a number that looks wrong?